Amoxicillin Powder for Injection 1g

Amoxicillin Powder for Injection 1g: What the Published Guidance Says

A broad portfolio spanning the WHO Access and Watch groups, supplied with the documentation that stewardship programmes and national tenders require.

Buyers usually settle three things before ordering Amoxicillin Powder for Injection 1g: the pharmacopoeial monograph, the pack configuration, and the documents the destination authority will ask for.

• WHO's own indication mapping is public — we align to it The WHO Antibiotics Portal lists amoxicillin as first choice for community-acquired pneumonia (mild to moderate), acute otitis media, acute sinusitis, acute pharyngitis and uncomplicated acute malnutrition in children; amoxicillin + clavulanic acid as first choice for severe community-acquired pneumonia in children, hospital-acquired pneumonia, cystitis and cellulitis; and ceftriaxone as first choice for severe acute pyelonephritis. WHO Antibiotics Portal — AWaRe
• Access group — the empirical workhorses The WHO AWaRe classification places amoxicillin, amoxicillin + clavulanic acid, ampicillin, clindamycin, gentamicin, metronidazole, chloramphenicol and doxycycline in the Access group. These are the medicines expected to be available in every functioning health system. WHO AWaRe (Access, Watch, Reserve) classification of antibiotics
• AWaRe is the framework buyers and stewards now work to WHO's AWaRe classification divides antibiotics into Access, Watch and Reserve. Access agents are described as those that should be widely available, affordable and quality-assured to improve access and promote appropriate use. Watch agents carry higher resistance potential and should be prioritised as targets of stewardship programmes and monitoring. WHO Antibiotics Portal — AWaRe

Each point above is reproduced because it has a practical consequence for Amoxicillin Powder for Injection 1g: the strength you can register, the pack you can release, or the wording permitted on the label. Your national prescribing information always takes precedence.

Amoxicillin Powder for Injection 1g — Supply Parameters

The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Levofloxacin Lactate Injection 100ml:300mg, Ciprofloxacin Lactate Injection 200mg/100mL, Netilmicin Injection 100mg/2ml, Metronidazole Injection 5mL:25mg, Gentamicin Injection 2mL:80mg, Clindamycin Injection 300mg/2mL, Ceftriaxone Powder for Injection 1g, Metronidazole Injection 500mg 100ml.

Quality Control, Pharmacopoeial Standards & Documentation

Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.

Release testing for Amoxicillin Powder for Injection 1g follows the monograph you nominate — USP, EP, BP or CP. If the presentation is not covered by a monograph, the specification is frozen in writing with your quality team before the batch is manufactured.

Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.

A typical release panel for this presentation covers:

• Testing for sterility and bacterial endotoxins (parenterals and ophthalmics)
• Testing for microbial limits and preservative efficacy (multi-dose presentations)
• Testing for heavy metals and elemental impurities
• Testing for packaging integrity and seal testing
• Testing for description and identification
• Testing for assay of the active substance

COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.

Packaging, Labelling & Export

• Pack size: 1g lyophilized powder in glass vial with rubber stopper and aluminum flip-off cap. Non-standard pack sizes can be quoted against your artwork.
• Storage: Store below 25°C, protected from light and moisture. Do not freeze. Keep vial in outer carton until use..
• Shelf life: 36 months (unopened, dry powder). Stability data for the marketed pack is included in the dossier.
• Labelling: artwork can be produced in English, Arabic, French, Russian and Spanish, with your own brand and language mix, subject to the labelling rules of the destination market.
• Export: GMP certificate, COA, certificate of origin, packing list and, where required, the free-sale or marketing authorisation certificate from the country of manufacture.

Registration, Dossier & Tender Support

The legal manufacturer named on every document for Amoxicillin Powder for Injection 1g is Sinophare Bio-technology Co., Ltd., DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. The same entity appears on the GMP certificate and on the dossier submitted to your regulator.

• CTD dossier modules 1–5 in editable and PDF form, with the finished-product and API sections cross-referenced.
• Site Master File and GMP certificate for the manufacturing workshops.
• Method validation, stability protocol and the shelf-life justification for the marketed pack.
• Answers to authority questions during assessment, handled by the regulatory contact who prepared the file.
• Tender and framework documentation, including pre-qualification questionnaires and sample logistics.

Amoxicillin Powder for Injection 1g is presented here against antibacterials classified in the WHO AWaRe framework. Inclusion in an essential-medicines list does not authorise sale in any particular country — the marketing authorisation for that market is a separate step.

Related Antibacterials Products

• Levofloxacin Lactate Injection 100ml:300mg — 100mL
• Ciprofloxacin Lactate Injection 200mg/100mL — 200mg/100mL
• Netilmicin Injection 100mg/2ml — 100mg/2mL
• Metronidazole Injection 5mL:25mg — 25mg/5mL
• Gentamicin Injection 2mL:80mg — 80mg/2mL
• Clindamycin Injection 300mg/2mL — 300mg/2mL

Browse the full Antibacterials range; all Injectables; the complete product catalogue.